A fiducial marker is a medical device that is mainly placed on the object or body so that it can mark the area that needs to get surgery. These markers are very tiny equipment of the size of rice grains, which can help to target cancerous tumours or tissues without affecting the healthy ones. This device enables to mark of the exact position of the tumour and can help the doctor to provide maximum radiation dose to the particular area consisting of the tumour without harming the surrounding tissues.

Market Dynamics

The growing adoption of radiotherapy devices by oncologists coupled with rising cases of cancer across the globe are the prime factors augmenting the product demand. Also, the surging demand for SBRT and IGRT procedures further boosts market growth.

Moreover, increasing awareness regarding the fiducial markers to give effective diagnosis further offers lucrative opportunities to the industry players. However, the requirement of placing fiducial markers before the CT scan will necessitate a second 3D scan before or during surgery can hamper the industry expansion.

Segment Analysis

Product Trends

By product, the fiducial markers market has been categorized into the gold, gold combination, polymer, and other metals, liquid.

Under these, the gold segment witnessed the highest market share in 2020 and is likely to register a significant CAGR during the review period.

This is mainly attributed to the accurate visibility and excellent stability of these products across various imaging modalities. Also, gold fiducial markers come in combination with various metals, such as platinum, titanium, and nickel, for better efficiency.

Regional Trends

By region, the North American market garnered the largest market share in 2020 and is projected to grow at a substantial CAGR during the assessment period.

This is mainly ascribed to streamlined reimbursement policies, the strong presence of key market players, and public health programs in the region. Growing healthcare expenditure and rising adoption of advanced radiotherapy procedures & imaging modalities further boosts the regional growth.

Key Players:               

• CIVCO Radiotherapy (The U.S),

• IZI Medical Products (The U.S),

• Naslund Medical AB (Sweden),

• Medtronic, Inc. (Ireland),

• QlRad Inc. (Netherlands),

• QFix (The U.S),

• Boston Scientific Corporation (The U.S),

• Nanovi A/S (Denmark),

• Eckert & Ziegler (Belgium), and

• IBA Dosimetry GmbH (Germany).